Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial
Published Online: 2014-09-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Cora N Sternberg•David Cella•David Forer•Ethan Basch•Howard I Scher•Johann S de Bono•Karim Fizazi•Kurt Miller•Mohammad Hirmand
